References
- Korea Central Cancer Registry. 2002 Annual Report of the Korea Central Cancer Registry 2003
- NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450 https://doi.org/10.1001/jama.264.11.1444
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740 https://doi.org/10.1056/NEJMoa040694
- Kim J, Cho M, Song K, et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002;54:403-408 https://doi.org/10.1016/S0360-3016(02)02856-0
- Twelves C, Wong A, Nowacki M, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005;352:2696-2704 https://doi.org/10.1056/NEJMoa043116
- National Comprehensive Cancer Network. Clinical practice guidelines in oncology V.2. 2009: Rectal cancer. http://www.nccn.org/professionals/physician_gls/PDC/rectal.pdf
- Chang HJ, Park CK, Kim WH, et al. A standardized pathology report for colorectal cancer. Korean J Path 2006;40:193-203
- Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-1472 https://doi.org/10.1056/NEJM198506063122301
- Pilipshen S, Heilweil M, Quan S, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53:1354-1362 https://doi.org/10.1002/1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO;2-J
- Krook J, Moertel C, Gunderson L, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715 https://doi.org/10.1056/NEJM199103143241101
- Douglass HJ, Moertel C, Mayer R, et al. Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294-1295 https://doi.org/10.1056/NEJM198611133152014
- Kapiteijn E, Marijnen C, Nagtegaal I, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646 https://doi.org/10.1056/NEJMoa010580
- De Paoli A, Chiara S, Luppi G, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006;17:246-251 https://doi.org/10.1093/annonc/mdj041
- Rullier E, Goffre B, Bonnel C, et al. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 2001;234:633-640 https://doi.org/10.1097/00000658-200111000-00008
- Rosenberg R, Nekarda H, Zimmermann F, et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 2008;97:8-13 https://doi.org/10.1002/jso.20844
- Capirci C, Valentini V, Cionini L, et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99-107 https://doi.org/10.1016/j.ijrobp.2007.12.019
- Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23 https://doi.org/10.1007/s003840050072
- Mandard A, Dalibard F, Mandard J, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680-2686 https://doi.org/10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
- Saif M, Hashmi S, Zelterman D, et al. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis 2008;23: 139-145 https://doi.org/10.1007/s00384-007-0382-z
- de Bruin A, Nuyttens J, Ferenschild F, et al. Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med 2008;66:71-76
- Das P, Skibber J, Rodriguez-Bigas M, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 2007; 109:1750-1755 https://doi.org/10.1002/cncr.22625
- O'Connell M, Martenson J, Wieand H, et al. Improving adjuvant therapy for rectal cancer by combining protractedinfusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-507 https://doi.org/10.1056/NEJM199408253310803
- Smalley S, Benedetti J, Williamson S, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006;24:3542-3547 https://doi.org/10.1200/JCO.2005.04.9544
- Scheithauer W, McKendrick J, Begbie S, et al. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol 2003;14:1735-1743 https://doi.org/10.1093/annonc/mdg500
- Bazarbashi S, El-Bassiouni M, Abdelsalam M, et al. A modern regimen of pre-operative concurrent chemo-radiation therapy in locally advanced rectal cancer. J Surg Oncol 2008; 98:167-174 https://doi.org/10.1002/jso.21097
- Di Costanzo F, Ravasio R, Sobrero A, et al. Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer: economic evaluation in an Italian NHS setting. Clin Drug Investig 2008;28:645-655 https://doi.org/10.2165/00044011-200828100-00005
- Dupuis O, Vie B, Lledo G, et al. Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study. Oncology 2007;73:169-176 https://doi.org/10.1159/000127383
- Aschele C, Friso M, Pucciarelli S, et al. A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005;16:1140-1146 https://doi.org/10.1093/annonc/mdi212
- Mehta V, Cho C, Ford J, et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasoundstaged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003;55: 132-137 https://doi.org/10.1016/S0360-3016(02)03863-4
- Glynne-Jones R, Sebag-Montefiore D, Maughan T, et al. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006;17:50-56 https://doi.org/10.1093/annonc/mdj031
- Choi SG, Bae HS. Results of preoperative concurrent chemoradiotherapy for locally advanced rectal cancer. J Korean Soc Ther Radiol Oncol 2007;25:34-42
- Luna-Pérez P, Rodríguez-Ramírez S, Rodriguez-Coria D, et al. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma. World J Surg 2001;25:1006-1011 https://doi.org/10.1007/s00268-001-0071-y
- Grann A, Feng C, Wong D, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987-995 https://doi.org/10.1016/S0360-3016(00)01529-7